grant PAR-25-346
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
This grant focuses on identifying cancer risks and strategies to reduce them, understanding factors that cause cancer, and developing methods for cancer prevention and interventions.
The purpose of this engineering-oriented notice of funding opportunity announcement (NOFO) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, s…
Funding Source
Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Awards & funding
Award Ceiling: $275,000
Eligibility
Higher Education Institutions – Private Institutions of Higher Education
Nonprofit Organizations without 501(c)(3) IRS Status (other than Institutions of Higher Education)
For-Profit Organizations (other than Small Businesses)
Eligible Agencies of the Federal Government
U.S. Territory or Possession
Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Native American Tribal Organizations (other than Federally recognized tribal governments)
Faith-based or Community-based Organizations
Regional Organizations
Foreign Organizations (Non-domestic, non-U.S. entities)
Non-domestic (non-U.S.) components of U.S. Organizations
- Required registrations (must be completed prior to submission; registration may take 6+ weeks and SAM must be renewed at least annually): SAM.gov with UEI (CAGE code for domestic orgs); NCAGE code for foreign organizations; eRA Commons (at least one Signing Official and one PD/PI account r…
Dates
Opportunity Released: December 11, 2024
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers